Peptide T minute chemical structure easily manufacture effectively block attack deadly AIDS virus human cell researcher claimed. The U.S. National Institute Mental Health announce third annual International Conference Acquired Immune Deficiency Syndrome Peptide T identify institute neuro-scientist Dr. Candace Pert "potently block entry AIDS virus cells..." The U.S. Food Drug Administration quickly approve clinical test naturally-occurring brain chemical. The decision make test AIDS victims. Dr. Frederick Goodwin institute's scientific director joint interview Pert "my gut reaction onto something." He base initial finding Peptide T hold promise treatment already suffer AIDS value search vaccine prevent spread disease. A research team found Peptide T capable fully reverse brain cell damage cause AIDS variety laboratory tests. Pert sent dos Peptide T autumn Swedish doctor provide chemical AIDS patients. One die survivor show improvement said. Goodwin major drug firm decline identify anxious win permission produce Peptide T substance potential find vaccine safeguard deadly disease threaten life million far. Pert clinical test United States involve dozen AIDS patient control environment probably start month hopefully verify chemical's usefulness. Reuter 